Dan Raftery, Professor of Analytical and Physical Chemistry
The Raftery Group uses and develops advanced methods in metabolomics for the discovery of early biomarkers of breast cancer. The emerging area of metabolomics describes the simultaneous detection and quantitative measurement of a large number of metabolites in biological samples such as normal and pathological tissue and bio-fluids. Detection of multiple metabolites, which are the end products of a multitude of genomic and proteomic functions promise immense applications in early diagnosis, prognosis and molecular level understanding of metabolic pathways associated with breast cancer.
For more information on Dr. Raftery, visit his department website here.